Anticancer potential of acetone extracts from selected Potentilla species against human colorectal cancer cells

Cinquefoils have been widely used in local folk medicine in Europe and Asia to manage various gastrointestinal inflammations and/or infections, certain forms of cancer, thyroid gland disorders, and wound healing. In the present paper, acetone extracts from aerial parts of selected Potentilla species...

Full description

Bibliographic Details
Main Authors: Daniel Augustynowicz, Marta Kinga Lemieszek, Jakub Władysław Strawa, Adrian Wiater, Michał Tomczyk
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.1027315/full
_version_ 1818029969863868416
author Daniel Augustynowicz
Marta Kinga Lemieszek
Jakub Władysław Strawa
Adrian Wiater
Michał Tomczyk
author_facet Daniel Augustynowicz
Marta Kinga Lemieszek
Jakub Władysław Strawa
Adrian Wiater
Michał Tomczyk
author_sort Daniel Augustynowicz
collection DOAJ
description Cinquefoils have been widely used in local folk medicine in Europe and Asia to manage various gastrointestinal inflammations and/or infections, certain forms of cancer, thyroid gland disorders, and wound healing. In the present paper, acetone extracts from aerial parts of selected Potentilla species, namely P. alba (PAL7), P. argentea (PAR7), P. grandiflora (PGR7), P. norvegica (PN7), P. recta (PRE7), and the closely related Drymocalis rupestris (syn. P. rupestris) (PRU7), were analysed for their cytotoxicity and antiproliferative activities against human colon adenocarcinoma cell line LS180 and human colon epithelial cell line CCD841 CoN. Moreover, quantitative assessments of the total polyphenolic (TPC), total tannin (TTC), total proanthocyanidins (TPrC), total flavonoid (TFC), and total phenolic acid (TPAC) were conducted. The analysis of secondary metabolite composition was carried out by LC-PDA-HRMS. The highest TPC and TTC were found in PAR7 (339.72 and 246.92 mg gallic acid equivalents (GAE)/g extract, respectively) and PN7 (332.11 and 252.3 mg GAE/g extract, respectively). The highest TPrC, TFC, and TPAC levels were found for PAL7 (21.28 mg catechin equivalents (CAT)/g extract, 71.85 mg rutin equivalents (RE)/g extract, and 124.18 mg caffeic acid equivalents (CAE)/g extract, respectively). LC-PDA-HRMS analysis revealed the presence of 83 compounds, including brevifolincarboxylic acid, ellagic acid, pedunculagin, agrimoniin, chlorogenic acid, astragalin, and tiliroside. Moreover, the presence of tri-coumaroyl spermidine was demonstrated for the first time in the genus Potentilla. Results of the MTT assay revealed that all tested extracts decreased the viability of both cell lines; however, a markedly stronger effect was observed in the colon cancer cells. The highest selectivity was demonstrated by PAR7, which effectively inhibited the metabolic activity of LS180 cells (IC50 = 38 μg/ml), while at the same time causing the lowest unwanted effects in CCD841 CoN cells (IC50 = 1,134 μg/ml). BrdU assay revealed a significant decrease in DNA synthesis in both examined cell lines in response to all investigated extracts. It should be emphasized that the tested extracts had a stronger effect on colon cancer cells than normal colon cells, and the most significant antiproliferative properties were observed in the case of PAR7 (IC50 LS180 = 174 μg/ml) and PN7 (IC50 LS180 = 169 μg/ml). The results of LDH assay revealed that all tested extracts were not cytotoxic against normal colon epithelial cells, whereas in the cancer cells, all compounds significantly damaged cell membranes, and the observed effect was dose-dependent. The highest cytotoxicity was observed in LS180 cells in response to PAR7, which, in concentrations ranging from 25 to 250 μg/ml, increased LDH release by 110%–1,062%, respectively. Performed studies have revealed that all Potentilla species may be useful sources for anti-colorectal cancer agents; however, additional research is required to prove this definitively.
first_indexed 2024-12-10T05:28:08Z
format Article
id doaj.art-c93471c6d5fe4d618806e65f605ad626
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-10T05:28:08Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-c93471c6d5fe4d618806e65f605ad6262022-12-22T02:00:39ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-09-011310.3389/fphar.2022.10273151027315Anticancer potential of acetone extracts from selected Potentilla species against human colorectal cancer cellsDaniel Augustynowicz0Marta Kinga Lemieszek1Jakub Władysław Strawa2Adrian Wiater3Michał Tomczyk4Department of Pharmacognosy, Medical University of Bialystok, Bialystok, PolandDepartment of Medical Biology, Institute of Rural Health, Lublin, PolandDepartment of Pharmacognosy, Medical University of Bialystok, Bialystok, PolandDepartment of Industrial and Environmental Microbiology, Maria Curie-Skłodowska University, Lublin, PolandDepartment of Pharmacognosy, Medical University of Bialystok, Bialystok, PolandCinquefoils have been widely used in local folk medicine in Europe and Asia to manage various gastrointestinal inflammations and/or infections, certain forms of cancer, thyroid gland disorders, and wound healing. In the present paper, acetone extracts from aerial parts of selected Potentilla species, namely P. alba (PAL7), P. argentea (PAR7), P. grandiflora (PGR7), P. norvegica (PN7), P. recta (PRE7), and the closely related Drymocalis rupestris (syn. P. rupestris) (PRU7), were analysed for their cytotoxicity and antiproliferative activities against human colon adenocarcinoma cell line LS180 and human colon epithelial cell line CCD841 CoN. Moreover, quantitative assessments of the total polyphenolic (TPC), total tannin (TTC), total proanthocyanidins (TPrC), total flavonoid (TFC), and total phenolic acid (TPAC) were conducted. The analysis of secondary metabolite composition was carried out by LC-PDA-HRMS. The highest TPC and TTC were found in PAR7 (339.72 and 246.92 mg gallic acid equivalents (GAE)/g extract, respectively) and PN7 (332.11 and 252.3 mg GAE/g extract, respectively). The highest TPrC, TFC, and TPAC levels were found for PAL7 (21.28 mg catechin equivalents (CAT)/g extract, 71.85 mg rutin equivalents (RE)/g extract, and 124.18 mg caffeic acid equivalents (CAE)/g extract, respectively). LC-PDA-HRMS analysis revealed the presence of 83 compounds, including brevifolincarboxylic acid, ellagic acid, pedunculagin, agrimoniin, chlorogenic acid, astragalin, and tiliroside. Moreover, the presence of tri-coumaroyl spermidine was demonstrated for the first time in the genus Potentilla. Results of the MTT assay revealed that all tested extracts decreased the viability of both cell lines; however, a markedly stronger effect was observed in the colon cancer cells. The highest selectivity was demonstrated by PAR7, which effectively inhibited the metabolic activity of LS180 cells (IC50 = 38 μg/ml), while at the same time causing the lowest unwanted effects in CCD841 CoN cells (IC50 = 1,134 μg/ml). BrdU assay revealed a significant decrease in DNA synthesis in both examined cell lines in response to all investigated extracts. It should be emphasized that the tested extracts had a stronger effect on colon cancer cells than normal colon cells, and the most significant antiproliferative properties were observed in the case of PAR7 (IC50 LS180 = 174 μg/ml) and PN7 (IC50 LS180 = 169 μg/ml). The results of LDH assay revealed that all tested extracts were not cytotoxic against normal colon epithelial cells, whereas in the cancer cells, all compounds significantly damaged cell membranes, and the observed effect was dose-dependent. The highest cytotoxicity was observed in LS180 cells in response to PAR7, which, in concentrations ranging from 25 to 250 μg/ml, increased LDH release by 110%–1,062%, respectively. Performed studies have revealed that all Potentilla species may be useful sources for anti-colorectal cancer agents; however, additional research is required to prove this definitively.https://www.frontiersin.org/articles/10.3389/fphar.2022.1027315/fullPotentillaRosaceaeLC-PDA-HRMSpolyphenolscolorectal cancerLS180 cells
spellingShingle Daniel Augustynowicz
Marta Kinga Lemieszek
Jakub Władysław Strawa
Adrian Wiater
Michał Tomczyk
Anticancer potential of acetone extracts from selected Potentilla species against human colorectal cancer cells
Frontiers in Pharmacology
Potentilla
Rosaceae
LC-PDA-HRMS
polyphenols
colorectal cancer
LS180 cells
title Anticancer potential of acetone extracts from selected Potentilla species against human colorectal cancer cells
title_full Anticancer potential of acetone extracts from selected Potentilla species against human colorectal cancer cells
title_fullStr Anticancer potential of acetone extracts from selected Potentilla species against human colorectal cancer cells
title_full_unstemmed Anticancer potential of acetone extracts from selected Potentilla species against human colorectal cancer cells
title_short Anticancer potential of acetone extracts from selected Potentilla species against human colorectal cancer cells
title_sort anticancer potential of acetone extracts from selected potentilla species against human colorectal cancer cells
topic Potentilla
Rosaceae
LC-PDA-HRMS
polyphenols
colorectal cancer
LS180 cells
url https://www.frontiersin.org/articles/10.3389/fphar.2022.1027315/full
work_keys_str_mv AT danielaugustynowicz anticancerpotentialofacetoneextractsfromselectedpotentillaspeciesagainsthumancolorectalcancercells
AT martakingalemieszek anticancerpotentialofacetoneextractsfromselectedpotentillaspeciesagainsthumancolorectalcancercells
AT jakubwładysławstrawa anticancerpotentialofacetoneextractsfromselectedpotentillaspeciesagainsthumancolorectalcancercells
AT adrianwiater anticancerpotentialofacetoneextractsfromselectedpotentillaspeciesagainsthumancolorectalcancercells
AT michałtomczyk anticancerpotentialofacetoneextractsfromselectedpotentillaspeciesagainsthumancolorectalcancercells